| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 136.268 | 160.515 | 174.950 | 201.516 | 235.655 | 201.294 | 281.229 | 264.361 | 279.977 | 241.214 |
| Total Income - EUR | 137.247 | 160.527 | 174.950 | 201.544 | 238.815 | 204.529 | 285.998 | 264.362 | 279.977 | 241.217 |
| Total Expenses - EUR | 141.724 | 162.496 | 170.485 | 191.036 | 233.937 | 211.237 | 281.973 | 254.767 | 284.884 | 255.444 |
| Gross Profit/Loss - EUR | -4.476 | -1.970 | 4.466 | 10.508 | 4.878 | -6.708 | 4.025 | 9.594 | -4.908 | -14.227 |
| Net Profit/Loss - EUR | -4.476 | -2.684 | -1.242 | 8.493 | 2.490 | -8.631 | 1.165 | 7.003 | -7.708 | -21.464 |
| Employees | 10 | 9 | 8 | 8 | 10 | 8 | 8 | 8 | 8 | 6 |
Check the financial reports for the company - Neuromed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.380 | 17.109 | 12.227 | 33.377 | 63.245 | 52.782 | 23.043 | 20.421 | 24.050 | 19.103 |
| Current Assets | -6.619 | -7.037 | 2.862 | 115 | -8.257 | -5.020 | 12.989 | 8.466 | 14.947 | 21.213 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.556 | 1.475 | 1.658 | 184 | 5.238 | 6.739 | 7.031 | 7.218 | 14.900 | 17.084 |
| Cash | -8.175 | -8.512 | 1.205 | -69 | -13.494 | -11.759 | 5.958 | 1.248 | 47 | 4.128 |
| Shareholders Funds | 653 | -2.038 | -3.246 | 5.307 | 2.540 | -6.139 | -4.838 | 49 | -7.659 | -29.080 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.108 | 12.110 | 18.336 | 30.334 | 52.486 | 53.902 | 40.869 | 28.838 | 46.656 | 69.396 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Neuromed S.r.l.